# Neostellar Capital Corp.: financial statements, quarterly

NSLR · Nasdaq · CIK 1509470 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nslr.md) · [Financials](/companies/nslr/financials.md) · [Filings](/companies/nslr/filings.md) · [Insiders](/companies/nslr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nslr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [1.2](/filings/0001493152-23-040034.md) | [1.2 d](/filings/0001493152-24-009905.md) | [1.2](/filings/0001493152-24-018344.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0 d](/filings/0001493152-24-044171.md) | [0.0 d](/filings/0001493152-26-009641.md) | [0.0](/filings/0001641172-25-008970.md) | [0.1](/filings/0001493152-25-011683.md) | [0.0 d](/filings/0001493152-25-020943.md) | [0.0 d](/filings/0001493152-26-009641.md) | [0.0](/filings/0001493152-26-021430.md) | [(0.2)](/filings/0001493152-26-036285.md) | [0.0 d](/filings/0001493152-25-020943.md) | [0.0 d](/filings/0001493152-26-009641.md) | [0.1](/filings/0001493152-26-021430.md) | [(0.0)](/filings/0001493152-26-036285.md) |
| Net income | $m | [25.2](/filings/0001493152-26-009641.md) | [(9.1)](/filings/0001493152-26-009641.md) | [(22.1)](/filings/0001493152-26-009641.md) | [(10.7)](/filings/0001493152-26-009641.md) | [(5.5)](/filings/0001493152-26-009641.md) | [0.0](/filings/0001493152-26-009641.md) | [(0.8)](/filings/0001493152-26-036285.md) | [62.3](/filings/0001493152-26-036285.md) | [7.4](/filings/0001493152-26-009641.md) | [(20.1)](/filings/0001493152-26-009641.md) | [156](/filings/0001493152-26-036285.md) | [(18.7)](/filings/0001493152-26-036285.md) |
| Diluted EPS | $ per share | [0.99](/filings/0001493152-26-009641.md) | [(0.36)](/filings/0001493152-26-009641.md) | [(0.87)](/filings/0001493152-26-009641.md) | [(0.45)](/filings/0001493152-26-009641.md) | [(0.23)](/filings/0001493152-26-009641.md) | not reported | [(0.03)](/filings/0001493152-26-021430.md) | [2.23](/filings/0001493152-26-036285.md) | [0.28](/filings/0001493152-26-009641.md) | [(0.80)](/filings/0001493152-26-009641.md) | [5.18](/filings/0001493152-26-021430.md) | [(0.72)](/filings/0001493152-26-036285.md) |
| Basic EPS | $ per share | [0.99](/filings/0001493152-26-009641.md) | [(0.36)](/filings/0001493152-26-009641.md) | [(0.87)](/filings/0001493152-26-009641.md) | [(0.45)](/filings/0001493152-26-009641.md) | [(0.23)](/filings/0001493152-26-009641.md) | not reported | [(0.03)](/filings/0001493152-26-021430.md) | [2.63](/filings/0001493152-26-036285.md) | [0.30](/filings/0001493152-26-009641.md) | [(0.80)](/filings/0001493152-26-009641.md) | [6.13](/filings/0001493152-26-021430.md) | [(0.72)](/filings/0001493152-26-036285.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [73.5](/filings/0001493152-23-040034.md) | [28.2](/filings/0001493152-25-009940.md) | [50.8](/filings/0001493152-24-018344.md) | [54.4](/filings/0001493152-24-030665.md) | [32.7](/filings/0001493152-24-044171.md) | [20.0](/filings/0001493152-26-009641.md) | [16.2](/filings/0001641172-25-008970.md) | [49.9](/filings/0001493152-25-011683.md) | [54.5](/filings/0001493152-25-020943.md) | [49.0](/filings/0001493152-26-036285.md) | [43.3](/filings/0001493152-26-021430.md) | [12.9](/filings/0001493152-26-036285.md) |
| Total assets | $m | [289](/filings/0001493152-23-040034.md) | [278](/filings/0001493152-25-009940.md) | [257](/filings/0001493152-24-018344.md) | [238](/filings/0001493152-24-030665.md) | [234](/filings/0001493152-24-044171.md) | [232](/filings/0001493152-26-009641.md) | [232](/filings/0001641172-25-008970.md) | [295](/filings/0001493152-25-011683.md) | [308](/filings/0001493152-25-020943.md) | [276](/filings/0001493152-26-036285.md) | [433](/filings/0001493152-26-021430.md) | [420](/filings/0001493152-26-036285.md) |
| Total liabilities | $m | [77.0](/filings/0001493152-23-040034.md) | [74.2](/filings/0001493152-25-009940.md) | [75.1](/filings/0001493152-24-018344.md) | [76.0](/filings/0001493152-24-030665.md) | [76.3](/filings/0001493152-24-044171.md) | [74.0](/filings/0001493152-26-009641.md) | [74.9](/filings/0001641172-25-008970.md) | [75.6](/filings/0001493152-25-011683.md) | [76.5](/filings/0001493152-25-020943.md) | [70.7](/filings/0001493152-26-036285.md) | [71.7](/filings/0001493152-26-021430.md) | [64.3](/filings/0001493152-26-036285.md) |
| Shareholders' equity | $m | [212](/filings/0001493152-23-040034.md) | [203](/filings/0001493152-25-009940.md) | [182](/filings/0001493152-24-018344.md) | [162](/filings/0001493152-24-030665.md) | [157](/filings/0001493152-24-044171.md) | [158](/filings/0001493152-26-009641.md) | [157](/filings/0001641172-25-008970.md) | [219](/filings/0001493152-25-011683.md) | [232](/filings/0001493152-25-020943.md) | [205](/filings/0001493152-26-036285.md) | [362](/filings/0001493152-26-021430.md) | [356](/filings/0001493152-26-036285.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [49.6 d](/filings/0001493152-24-044171.md) | [(45.3) d](/filings/0001493152-26-009641.md) | [22.7](/filings/0001641172-25-008970.md) | [13.0 d](/filings/0001493152-25-011683.md) | [(20.9) d](/filings/0001493152-25-020943.md) | [(12.4) d](/filings/0001493152-26-009641.md) | [(3.7)](/filings/0001493152-26-021430.md) | [33.7 d](/filings/0001493152-26-036285.md) | [(0.1) d](/filings/0001493152-25-020943.md) | [4.4 d](/filings/0001493152-26-009641.md) | [(5.8)](/filings/0001493152-26-021430.md) | [(24.1) d](/filings/0001493152-26-036285.md) |
| Dividends paid | $m | [0.0 d](/filings/0001493152-24-044171.md) | [0.0 d](/filings/0001493152-26-009641.md) | [0.1](/filings/0001641172-25-008970.md) | [0.0 d](/filings/0001493152-25-011683.md) | [0.0 d](/filings/0001493152-25-020943.md) | [0.0 d](/filings/0001493152-26-009641.md) | [0.0](/filings/0001493152-26-021430.md) | [0.0 d](/filings/0001493152-26-036285.md) | [5.8 d](/filings/0001493152-25-020943.md) | [6.2 d](/filings/0001493152-26-009641.md) | [0.0](/filings/0001493152-26-021430.md) | [0.3 d](/filings/0001493152-26-036285.md) |
| Share repurchases | $m | [0.7 d](/filings/0001493152-24-044171.md) | [0.0 d](/filings/0001493152-26-009641.md) | not reported | not reported | [0.0 d](/filings/0001493152-25-020943.md) | [0.0 d](/filings/0001493152-26-009641.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.4](/filings/0001493152-26-009641.md) | [25.3](/filings/0001493152-26-009641.md) | [25.4](/filings/0001493152-26-009641.md) | [23.4](/filings/0001493152-26-009641.md) | [23.4](/filings/0001493152-26-009641.md) | [23.4](/filings/0001493152-26-009641.md) | [23.6](/filings/0001493152-26-021430.md) | [28.2](/filings/0001493152-26-036285.md) | [29.0](/filings/0001493152-26-009641.md) | [25.2](/filings/0001493152-26-009641.md) | [30.2](/filings/0001493152-26-021430.md) | [26.0](/filings/0001493152-26-036285.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 26,473,222 at 2026-09-23, from the cover of the [10-K/A filed 2026-09-23](/filings/0001493152-26-043924.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.